Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Research Article Volume 7 Issue 11

Kidney Damage in Hematological Diseases in the Oncology Hematology Department of the National Donka Hospital

Alpha Boubacar Bah1*, Mamadou Saliou Balde1, Aly Traoré1, A Kanté2, Amadou Aziz Diallo1, Fousseny Diakité1, Amadou yaya Diallo1, Kadiatou Bobo Diallo1, Soriba bangoura1, Mohamed Lamine Kaba1 and Alpha Oumar Bah1

1Service de Néphrologie-Hémodialyse du CHU de Donka, Guinea
2Service Hématologie-Oncologie du CHU Donka, Guinea

*Corresponding Author: Alpha Boubacar Bah, Service de Néphrologie-Hémodialyse du CHU de Donka, Guinea.

Received: August 22, 2023; Published: October 03, 2023


Introduction: Kidney disease is a major public health problem. Kidney damage is common in hematological diseases. The objective of our study was to look for kidney damage in hematological diseases. Material and Methods: We did a retrospective study lasting 2 years from January 1, 2019 to December 31, 2020, in the hematology department of Donka National Hospital. We included all the files of patients followed for benign or malignant hematological disease, then we looked for an anomaly of renal function, an anomaly on the urinary dipstick.

Results: Of a total of 480 records reviewed, we found that 53 patients had kidney disease (11.04%). The average age was 49 years ± 13.78. there a male predominance 28 (52.83%) against 25 (47.17%) among women. The comorbidities encountered during the study were hypertension in 20 patients. The most frequent hematological pathology in the study was sickle cell disease in 19 patients (35.84%) followed by myeloma in 8 patients (15.09%). Renal damage encountered during these hematological diseases was associated with acute renal failure 16 (30.18%) and chronic renal failure 19 (35.84%), without renal failure 18 (34.34%).

Conclusion: Our study allowed us to understand the high frequency of renal involvement in hematological pathologies that affected relatively young subject. Kidney damage can be acute or chronic, hence the need for early management through screening.

Keywords: Kidney Disease; Chronic Renal Failure


  1. Chen TK., et al. "Chronic kidney disease diagnosis and management". JAMA 322 (2019): 1294-1304.
  2. Kyelem C G., et al. "Diagnostic et prise en charge de la maladie rénale chronique dans un contexte de ressources limitées : spécificités et difficultés d’un service de Médecine interne". RAFMI 7:11-19.
  3. Imen C., et al. "Insuffisance rénale aigue révélatrice d’un lymphome rénal. A propos d’un cas". Néphrologie and Thérapeutique 6 (2010): 132-136.
  4. Leblanc T. "Leucémies aiguës de l’enfant et de l’adolescent : Quand penser à ce diagnostic?" Le Concours Médical 9 (2015): 699-670.
  5. Aneke JC., et al. "Degrees of kidney disease in Nigerian adults with sickle cell disease". Medical Principles and Practice 23 (2014): 279-284.
  6. "Atteinte rénale au cours du myélome multiple à propos de 95 cas. Thèse en médecine 2016". Université de Fès. P108.enquête sur la recherche des marqueurs urinaires d’atteinte rénale en médecine interne.
  7. P Strati., et al. "Complications rénales dans la leucémie lymphoïde chronique et la lymphocytose monoclonale à cellules B : l'expérience de la clinique Mayo". Haematologica 100 (2015): 1180-1188.
  8. Canet E., et al. "Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival". PLoS One2 (2013).
  9. Corlu L., et al. "Renal Dysfunction in Patients With Direct Infiltration by B-Cell Lymphoma". Kidney International Reports5 (2019): 688-697.


Citation: Alpha Boubacar Bah., et al. “Kidney Damage in Hematological Diseases in the Oncology Hematology Department of the National Donka Hospital".Acta Scientific Pharmaceutical Sciences 7.11 (2023): 03-05.


Copyright: © 2023 Alpha Boubacar Bah., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US